The Medical Advisor

Executive Summary Rates of several cancers are increasing among younger adults in many countries, even as overall cancer mortality continues to decline. This has triggered understandable concern and a surge of commentary linking cancer risk to immune dysfunction, infections, pharmaceuticals, diet, and modern lifestyles. Some of these connections are supported by solid evidence; others are speculative or misleading. This article provides a balanced, evidence‑based review of what scientists know so far — clearly separating established facts , plausible hypotheses , and claims not supported by credible data . Keywords:  rising cancer rates, early-onset cancer, immune health and cancer, metabolic health, cancer risk factors, cancer prevention evidence Credit:  Statista 1. Are Cancer Rates Really Rising? (Early-Onset Cancer Trends) Yes — but selectively. Large population studies show that incidence is rising for certain cancers in adults under 50, including: Colorectal cancer Brea...

Introduction What is the "Stanford Fenbendazole Protocol"? I bet you've never heard of the "Stanford Fenbendazole Protocol" for treating Cancer. Yet, it exists. But it's heavily suppressed by search engines and mainstream Oncology, especially in the United States and Canada. In 2021 a group at Stanford University Medical Center, Department of Medicine, published a Case Series (Clin. Oncol. Case Rep 2021)* on a "forbidden" repurposed drug, Fenbendazole. *Note: Clinical Oncology Case Reports is a peer-reviewed International clinical and medical oncology and cancer research Journal. Clinical Oncology Case Reports (COCR) is a high-impact multidisciplinary journal focus on the area of clinical and medical investigation. They wrote about 3 cases of Stage 4 Cancer patients who self-treated and cured their cancers.   Case 1: 63 year old man with a Stage 4 Renal Cell Carcinoma (clear cell) , a 5.3cm mass and mets to pancreas and bone, failed 3 lines of ...